🇨🇦 Canada Country × Condition
multiple myeloma Clinical Trials in Canada
Active clinical trials for multiple myeloma with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 3 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇨🇦 Canada
Active Trials in Canada (5)
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
135 pts
Country
🇨🇦 Canada
AbbVie
View Trial → NCT06182774 Phase 3
Recruiting
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Enrollment
570 pts
Country
🇨🇦 Canada
Canadian Cancer Trials Group
View Trial → NCT06988488 Phase 1, Phase 2
Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Enrollment
62 pts
Country
🇨🇦 Canada
Celgene
View Trial → NCT05650632 Phase 1
Recruiting
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Enrollment
250 pts
Country
🇨🇦 Canada
AbbVie
View Trial → NCT05272826 Phase 2
Recruiting
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
Enrollment
75 pts
Country
🇨🇦 Canada
Canadian Myeloma Research Group
View Trial → Frequently Asked Questions
How many multiple myeloma clinical trials are active in Canada?
There are currently 5 active clinical trials for multiple myeloma with sites in Canada, of which 5 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Canada?
To join a multiple myeloma clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Canada?
Active multiple myeloma trials in Canada span Phase 1, Phase 3, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology